These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19735500)

  • 1. To RBC or not to RBC: the role of suicidal death in hemolytic transfusion reactions.
    Zimring JC; Spitalnik SL
    Transfusion; 2009 Sep; 49(9):1776-8. PubMed ID: 19735500
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M; Heidemann SM; Sarnaik AP; Meert KL; Sarnaik SA
    J Pediatr Hematol Oncol; 1999; 21(1):70-3. PubMed ID: 10029818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD; Williams ME
    Ann Clin Lab Sci; 1986; 16(3):214-8. PubMed ID: 3717883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
    Roumenina LT; Bartolucci P; Pirenne F
    Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A response to 'delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    Chincholkar M
    Anaesthesia; 2005 Nov; 60(11):1156; author reply 1156. PubMed ID: 16229715
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
    Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
    Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of acute hemolytic transfusion reactions.
    Uhl L; Johnson ST
    Immunohematology; 2007; 23(3):93-9. PubMed ID: 18284298
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhemolysis in sickle cell disease.
    Aragona E; Kelly MJ
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e54-6. PubMed ID: 23619113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F
    Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems of chronic transfusion in sickle cell disease.
    Orlina AR; Sosler SD; Koshy M
    J Clin Apher; 1991; 6(4):234-40. PubMed ID: 1816246
    [No Abstract]   [Full Text] [Related]  

  • 20. Warm autoimmune hemolytic anemia.
    Naik R
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.